GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Viropro VPRO · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Viropro — daily VPRO Delayed
Market value
$4,951
Last close × shares
Volume
75k
Shares, 30 Oct 2026

About Viropro

Its shares trade under the ticker VPRO. It has been listed since 21 June 2001. In the fiscal year to 31 December 2010, it reported revenue of $571,098 and a net loss of $1.0m. At that date it held total assets of $2.1m and shareholders' equity of $1.5m.

Viropro, Inc. engages in the development, manufacture and sale of biopharmaceutical products. The company is headquartered in Irvine, California. The company went IPO on 2001-06-21. The firm conducts operations primarily through its subsidiary, Alpha Biologics Sdn Bhd (Alpha) located in Penang, Malaysia. The firm intends to offer solution to the biopharma industry from drug concept through to product manufacturing. The Alpha facility consists of approximately 50,000 square feet of research and production space. The Alpha facility is designed to support the scale-up and manufacture of monoclonal antibodies.

Figures and description from our data supplier, not checked against the company's own report.

More about Viropro →

Latest on Viropro

Our reporting

We have not reported on Viropro yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Viropro's ticker?

Viropro trades as VPRO on its US listing, under ISIN US9282422057.

What was Viropro's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.